-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Ambrx Biopharma Cayman, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from 2021 to Q2 2023.
- Ambrx Biopharma Cayman, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Jun 2023 was 391,283,214, a 45% increase year-over-year.
- Ambrx Biopharma Cayman, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 270,241,698, a 89% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)